Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers at the Nuffield Department of Women’s & Reproductive Health (NDWRH) are today starting a large, international study to evaluate the effects of Covid-19 in pregnancy.

Pregnant woman having 4D ultrasound scan

The INTERCOVID study will provide women, families, health care providers and policy makers with high-quality evidence regarding the effects of Covid-19 in pregnancy on the health of the mother, fetus and newborn.

The information is needed quickly and at scale to optimise pregnancy care, reduce maternal anxiety, inform decision-making about the allocation of resources, and guide the process toward social adaptation. Although it is generally believed that pregnant women with Covid-19 are at similar risk to the general population, there is limited data available, principally from small studies without controls, which cannot answer fundamental questions relating to the effects of the disease on maternal and neonatal outcomes.

Read the full story on the University of Oxford website